Education
About Us
Working with TipRanks
Follow Us
Genetic Signatures Ltd. (AU:GSS)
:GSS
RESEARCH TOOLSreports
GSS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.48 - AU$0.85
Previous CloseN/A
Volume34.30K
Average Volume (3M)101.25K
Market Cap
AU$113.57M
Enterprise ValueAU$116.20M
Total Cash (Recent Filing)AU$8.82M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding227,138,820
10 Day Avg. Volume149,913
30 Day Avg. Volume101,245
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.05Price Target Upside110.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Genetic Signatures Ltd. News
PremiumCompany Announcements
Genetic Signatures Ltd. Announces Cessation of Securities
PremiumCompany Announcements
Genetic Signatures Reports Strong Sales Growth and Strategic Shift in FY25
PremiumCompany Announcements
Genetic Signatures Reports Revenue Surge Amid Rising Losses
PremiumCompany Announcements
Genetic Signatures Addresses Late Lodgement of Director’s Change Notice
PremiumCompany Announcements
Genetic Signatures Boosts Sales Amidst US Market Expansion
PremiumCompany Announcements
Genetic Signatures Director Increases Shareholding
PremiumCompany Announcements
Genetic Signatures Ltd. Announces New Securities QuotationPremiumCompany Announcements
Genetic Signatures Issues New Equity Securities---
Options Prices
Currently, No data available
---
Ownership Overview
1.65% Insiders
―
Mutual Funds
― Other Institutional Investors
98.35% Public Companies and
Individual Investors
GSS FAQ
What was Genetic Signatures Ltd.’s price range in the past 12 months?
Genetic Signatures Ltd. lowest share price was AU$0.47 and its highest was AU$0.85 in the past 12 months.
What is Genetic Signatures Ltd.’s market cap?
Genetic Signatures Ltd.’s market cap is AU$113.57M.
When is Genetic Signatures Ltd.’s upcoming earnings report date?
Genetic Signatures Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 148 days.
How were Genetic Signatures Ltd.’s earnings last quarter?
Genetic Signatures Ltd. released its earnings results on Feb 25, 2025. The company reported -AU$0.069 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.069.
Is Genetic Signatures Ltd. overvalued?
According to Wall Street analysts Genetic Signatures Ltd.’s price is currently Undervalued.
Does Genetic Signatures Ltd. pay dividends?
Genetic Signatures Ltd. does not currently pay dividends.
What is Genetic Signatures Ltd.’s EPS estimate?
Genetic Signatures Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Signatures Ltd. have?
Genetic Signatures Ltd. has 227,138,820 shares outstanding.
What happened to Genetic Signatures Ltd.’s price movement after its last earnings report?
Genetic Signatures Ltd. reported an EPS of -AU$0.069 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14%.
Which hedge fund is a major shareholder of Genetic Signatures Ltd.?
Currently, no hedge funds are holding shares in AU:GSS
---
Genetic Signatures Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.05 (110.00% Upside)
AU$1.05 (110.00% Upside)
Blogger Sentiment
Bullish
AU:GSS Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth AU$50.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.14%
12-Months-Change
Fundamentals
Return on Equity
-47.52%
Trailing 12-Months
Asset Growth
32.75%
Trailing 12-Months
Company Description
Genetic Signatures Ltd.
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
---
GSS Stock 12 Month Forecast
Average Price Target
AU$1.05
▲(110.00% Upside)
Technical Analysis
Imugene Limited
―
Telix Pharmaceuticals Ltd.
―
BCAL Diagnostics Limited
―
Race Oncology Ltd.
―
Proteomics International Laboratories Ltd.
―
Best Analysts Covering GSS
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+4.37%
reiterated a buy rating 11 months ago
Copying Dennis Hulme's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.37% per trade.
---